FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 267

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
LFCR Nasdaq Lifecore Biomedical, Inc. 2830
LITS Nasdaq Lite Strategy, Inc. 2830
LNAI Nasdaq Lunai Bioworks Inc. 2830
LQDA Nasdaq Liquidia Corporation 2830
LRMR Nasdaq Larimar Therapeutics, Inc. 2830
LSTA Nasdaq Lisata Therapeutics, Inc. 2830
LYEL Nasdaq Lyell Immunopharma, Inc. 2830
LZAGY Over the counter Lonza Group AG 2830
MAZE Nasdaq Maze Therapeutics, Inc. 2830
MBIO Nasdaq Mustang Bio, Inc. 2830
MDCX Nasdaq Medicus Pharma Ltd. 2830
MEJHY Over the counter Meiji Holdings Co., Ltd. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MLYS Nasdaq Mineralys Therapeutics, Inc. 2830
MOLN Nasdaq Molecular Partners AG 2830
MPLT Nasdaq MapLight Therapeutics, Inc. 2830
MRNA Nasdaq Moderna, Inc. 2830
MSLE Nasdaq Satellos Bioscience Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
MTVA Nasdaq MetaVia Inc. 2830
NAGE Nasdaq Niagen Bioscience, Inc. 2830
NBTX Nasdaq Nanobiotix S.A. 2830
NCEL Nasdaq NewcelX Ltd. 2830
NCNA Nasdaq NuCana plc 2830
NEOG Nasdaq Neogen Corporation 2830
NEUP Nasdaq Neuphoria Therapeutics Inc. 2830
NMRA Nasdaq Neumora Therapeutics, Inc. 2830
NNVC NYSE American NanoViricides, Inc. 2830
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2830
NSRX NYSE American Nasus Pharma Ltd. 2830
NVCT Nasdaq Nuvectis Pharma, Inc. 2830
NVS New York Novartis AG 2830
NXTS Nasdaq Nexentis Technologies Inc. 2830
OCS Nasdaq Oculis Holding AG 2830
ODTX Nasdaq Odyssey Therapeutics, Inc. 2830
OGEN NYSE American Oragenics, Inc. 2830
OGN New York Organon & Co. 2830
ONCO Nasdaq Onconetix, Inc. 2830
ONCY Nasdaq Oncolytics Biotech Inc. 2830
OPK Nasdaq OPKO Health, Inc. 2830
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2830
ORXOY Over the counter Orexo AB (publ) 2830
OVID Nasdaq Ovid Therapeutics Inc. 2830
PALI Nasdaq Palisade Bio, Inc. 2830
PBYI Nasdaq Puma Biotechnology, Inc. 2830
PCRX Nasdaq Pacira BioSciences, Inc. 2830
PCVX Nasdaq Vaxcyte, Inc. 2830
PDSB Nasdaq PDS Biotechnology Corporation 2830
PFE New York Pfizer Inc. 2830
PG New York The Procter & Gamble Company 2830
Results 150 through 200 of 267